Receptor-ligand ROBO1-SLIT2 cancer-stroma interaction has been shown to reduce tumor cell proliferation by reducing PI3K-β-catenin and SDF1-CXCR4 signal transduction and consequent cancer cell malignancy [71, 72]. The gene discussed is CXCR4; the disease is cancer.